### 6. the operator of a dlt market infrastructure shall establish a clear , detailed and publically available strategy for transitioning out of or winding down a particular dlt market infrastructure (referred to herein as the ‘transition strategy’) , ready to be deployed in a timely manner , in the event that the permission or some of the exemptions granted in accordance with article 4 or article 5 have to be withdrawn or otherwise discontinued , or in the event of any voluntary or involuntary cessation of the business of the dlt mtf or dlt securities settlement system. the transition strategy shall set out how members , participants , issuers and clients shall be treated , in the event of such withdrawal , discontinuation or cessation. the transition strategy shall be updated on an ongoing basis subject to the prior consent of the competent authority which granted the permission to operate and related exemptions under article 4 and article 5. ### 6. the operator of a dlt market infrastructure shall establish a clear , detailed and publicly available strategy for transitioning out of or winding down a particular dlt market infrastructure (referred to herein as the ‘transition strategy’) , including the transition or reversion of their dlt operations to traditional infrastructures , ready to be deployed in a timely manner , in the event that the permission or some of the exemptions granted in accordance with article 4 or article 5 have to be withdrawn or otherwise discontinued , or the thresholds envisaged in this regulation have been reached or in the event of any voluntary or involuntary cessation of the business of the dlt mtf or dlt sss. the transition strategy shall set out how members , participants , issuers and clients shall be treated , in the event of such withdrawal , discontinuation or cessation. the transition strategy shall be updated on an ongoing basis subject to the prior consent of the competent authority which granted the permission to operate and related exemptions under article 4 and article 5.


### where applicable , the functioning of its proprietary dlt as referred to in article 6(2); ### where applicable , the functioning of the dlt used as referred to in article 6(2);


### the exemptions it is requesting in accordance with article 4 , the justification for each exemption sought , any compensatory measures proposed as well as the means envisaged to comply with the conditions attached to such exemptions under article 4. ### the exemptions it is requesting in accordance with article 4 , the justification for each exemption sought , any compensatory or corrective measures proposed as well as the means envisaged to comply with the conditions attached to such exemptions under article 4.


### 3. before deciding on an application for a specific permission to operate a dlt mtf under this regulation , the competent authority of the home member state shall notify and provide all relevant information on the dlt mtf to esma , an explanation of the exemptions requested , their justifications and any compensatory measures proposed by the applicant or required by the competent authority. ### 3. before deciding on an application for a specific permission to operate a dlt mtf under this regulation , the competent authority of the home member state shall notify and provide all relevant information on the dlt mtf to esma , an explanation of the exemptions requested , their justifications and any compensatory or corrective measures proposed by the applicant or required by the competent authority.


### within three months of receipt of the notification , esma shall provide the competent authority with a non-binding opinion on the application and shall make any recommendations on the exemptions requested by the applicant , that are necessary to ensure investor protection , market integrity and financial stability. esma shall also promote the consistency and proportionality of exemptions granted by competent authorities to investment firms or market operators operating dlt mtfs across the union. in order to do so , esma , shall consult the competent authorities of the other member states in a timely manner and take the utmost account of their views in its opinion. ### within three months of receipt of the notification , esma shall provide the competent authority with a recommendation issued in accordance with article 16 of regulation (eu) no 1095/2010 on the application and shall make any recommendations on the exemptions requested by the applicant , that are necessary to ensure investor protection , market integrity and financial stability. esma shall also promote the consistency and proportionality of exemptions granted by competent authorities to investment firms or market operators operating dlt mtfs across the union. in order to do so , esma , shall consult the competent authorities of the other member states in a timely manner and take the utmost account of their views in its recommendation.


### esma shall publish on its website the list of dlt mtfs , the start and end dates of their specific permissions and the list of exemptions granted to each of them. ### esma shall publish on its website (a) the list of dlt mtfs , the start and end dates of their specific permissions and the list of exemptions granted to each of them , and (b) the total number of requests for exemptions that have been made under this regulation , indicating the number of exemptions accepted or refused together with the respective justifications , on an anonymous basis.


### 7. where in the course of its activity , an investment firm or a market operator operating a dlt mtf proposes to introduces a material change to the functioning of the dlt , or to its services or activities , which requires a new permission , a new exemption , or the modification of one or more of its existing exemptions or of any conditions attached to it , it shall request such permission , exemption or modification in accordance with article 4. such permission , exemption or modification shall be processed by the competent authority , in accordance with paragraphs 2 to 5. ### 7. where in the course of its activity , an investment firm or a market operator operating a dlt mtf proposes to introduce a material change to the functioning of the dlt , or to its services or activities , which requires a new permission , a new exemption , or the modification of one or more of its existing exemptions or of any conditions attached to it , it shall request such permission , exemption or modification in accordance with article 4. such permission , exemption or modification shall be processed by the competent authority , in accordance with paragraphs 2 to 5.


### the functioning of its proprietary dlt as referred to in article 6(2); ### the functioning of its dlt as referred to in article 6(2);


### the exemptions it is requesting , in accordance with article 5 , the justifications for each exemption sought , any compensatory measures proposed as well as the measures envisaged to comply with the conditions attached to such exemptions under article 5. ### the exemptions it is requesting , in accordance with article 5 , the justifications for each exemption sought , any compensatory or corrective measures proposed as well as the measures envisaged to comply with the conditions attached to such exemptions under article 5.


### 3. before deciding on an application for a specific permission to operate a dlt mtf under this regulation , the competent authority shall notify and provide all relevant information on the dlt securities settlement system to esma and an explanation of the exemptions requested , their justification and any compensatory measures proposed by the applicant or required by the competent authority. ### 3. before deciding on an application for a specific permission to operate a dlt sss under this regulation , the competent authority shall notify and provide all relevant information on the dlt sss to esma and an explanation of the exemptions requested , their justification and any compensatory or corrective measures proposed by the applicant or required by the competent authority.


### esma shall publish on its website the list of dlt securities settlement systems , the start and end dates of their specific permissions and the list of exemptions granted to each of them. ### esma shall publish on its website (a) the list of dlt ssss , the start and end dates of their specific permissions and the list of exemptions granted to each of them , and (b) the total number of requests for exemptions that have been made under this regulation , indicating the number of exemptions accepted or refused together with the respective justifications , on an anonymous basis.


### the number and value of dlt transferable securities admitted to trading on the dlt mtf , the number and value of dlt transferable securities recorded by a csd operating dlt securities settlement systems , and where applicable , the number and value of transferable securities recorded by an investment firm or market operator operating on a dlt mtf; ### the number and value of dlt transferable securities admitted to trading on the dlt mtf , the number and value of dlt transferable securities recorded by a csd operating dlt ssss , and where applicable , the number and value of transferable securities recorded by an investment firm or market operator operating on a dlt mtf;


### the number and value of transactions traded on a dlt mtf and settled either by a csd operating a dlt securities settlement system , or where applicable , by an investment firm or market operator operating a dlt mtf; ### the number and value of transactions traded on a dlt mtf and settled either by a csd operating a dlt sss , or where applicable , by an investment firm or market operator operating a dlt mtf;


### 5. esma shall fulfil a coordination role between competent authorities , with a view to building a common understanding of distributed ledger technology and dlt market infrastructure as well as a common supervisory culture and convergent supervisory practices , ensuring consistent approaches and convergence in supervisory outcomes. ### 5. esma shall fulfil a coordination role between competent authorities , with a view to building a common understanding of distributed ledger technology and dlt market infrastructure as well as a common supervisory culture and convergent supervisory practices , ensuring consistent approaches and convergence in supervisory outcomes. esma shall create an ad hoc consultative committee in the form of a stakeholders’ group , bringing together representatives of both public and private stakeholders for a limited period of time equivalent to the duration of the operation of the pilot regime. the ad hoc consultative committee shall undertake the preparatory and consultative work needed to support esma in the issuance of the recommendations envisaged under this regulation , by transmitting a written statement to esma setting out the reasons for a refusal of an exemption , or for a permission that the committee considers to be insufficiently reasoned or ill-suited to the requirements of this regulation. the ad hoc consultative committee shall examine complaints submitted directly to esma in cases where an applicant considers that its exemption request or permission to participate under the pilot regime has been inappropriately denied by its relevant national competent authority. in order to avoid the submission of abusive complaints to esma by applicants , only complete and well-documented complaints transmitted to the consultative committee shall be analysed. the ad hoc consultative committee may request a shortened delay of transmission after the response of the relevant nca and may also request that a set of documentation be transmitted to the consultative committee , including in particular a summary of the applicant’s activities and the requested exemption(s). the relevant documents submitted , as well as the decision of the nca refusing the requested exemption(s) and or permission , shall be translated into english.


### 1. five years from the entry into application of this regulation , at the latest , esma shall present a report to the commission on: ### 1. esma shall present to the commission an early-exit assessment report by ... [the three-year period assessment for the early-exit assessment should be calculated from the date of the entry into force of this regulation , hence including the 12 months period needed for the draft regulatory technical standards , as envisaged in this regulation] and , if the regime prescribed in this regulation is not terminated by then , a final report by [five years from the entry into application of this regulation] on:


### the number of dlt mtfs and csds operating a dlt securities settlement system which have been granted a specific permission under this regulation; ### the number of dlt mtfs and csds operating a dlt sss which have been granted a specific permission under this regulation;


### the number and value of dlt transferable securities admitted to trading on dlt mtfs , the number and value of dlt transferable securities recorded by csds operating dlt securities settlement systems , and where applicable , the number and value of transferable securities recorded by dlt mtfs; ### the number and value of dlt transferable securities admitted to trading on dlt mtfs , the number and value of dlt transferable securities recorded by csds operating dlt ssss , and where applicable , the number and value of transferable securities recorded by dlt mtfs;


### the number and value of transactions traded on dlt mtfs and settled by csds operating dlt securities settlement system , and where applicable , by dlt mtfs; ### the number and value of transactions traded on dlt mtfs and settled by csds operating dlt sss , and where applicable , by dlt mtfs;


### the benefits resulting from the use of a dlt , in terms of any efficiency improvements and risk reductions across the entire trading and post-trading chain , including without limitation , with regard to the recording and safekeeping of dlt transferable securities , the traceability of transactions , corporate actions , reporting and supervision functions at the level of the dlt market infrastructure; ### the benefits and costs resulting from the use of a dlt , in terms of any efficiency improvements and risk mitigation across the entire trading and post-trading chain , including without limitation , with regard to the recording and safekeeping of dlt transferable securities , the traceability of transactions , corporate actions , reporting and supervision functions at the level of the dlt market infrastructure;


### 2. based on the report referred to in paragraph 1 , the commission shall present a report to the european parliament and council including a cost-benefit analysis on whether the regime for dlt market infrastructures under this regulation should be: ### 2. based on the reports referred to in paragraph 1 , the commission shall present a report to the european parliament and council within three months of receipt of each report , including a cost-benefit analysis on whether the regime for dlt market infrastructures under this regulation should be:


### extended for another period; ### extended for another period of two years , in the case of the early-exit assessment report referred to in article 10 , paragraph 1;


### 1. stresses its commitment to the 2030 agenda , especially in light of the new geopolitical landscape and the ongoing climate , biodiversity and health crises; warns against further polarisation in the distribution of wealth and income , which would lead to increased inequality and poverty; highlights , against this backdrop , the importance of the sdgs , which provide a universal compass for people’s prosperity and to protect the planet; recalls that a pledge to leave no one behind lies at the heart of the 2030 agenda and that the achievement of the sdgs should benefit all countries , people and segments of society; ### 1. stresses its commitment to the 2030 agenda , especially in light of the new geopolitical landscape brought about by the russian war of aggression against ukraine and the ongoing climate , biodiversity , health , debt and food security crises; warns against further polarisation in the distribution of wealth and income , which would lead to increased inequality and poverty; highlights , against this backdrop , the importance of the sdgs , which provide a universal compass for people’s prosperity and to protect the planet; recalls that a pledge to leave no one behind lies at the heart of the 2030 agenda and that the achievement of the sdgs should benefit all countries , people and segments of society;


### 2. highlights the fact that , at the halfway point in the 2030 agenda timeline , eu leadership in the global implementation of the sdgs remains crucial; underlines that 2023 offers a unique opportunity to gather momentum and undertake the urgent transformative action required to place our societies firmly on course to achieve the sdgs; warns that the consequences of inaction in this crucial year would primarily be borne by the most vulnerable people; ### 2. highlights the fact that , at the halfway point in the 2030 agenda timeline , eu leadership in the global implementation of the sdgs remains crucial , especially in taking the lead to mobilize adequate financial resources to support sdg-relevant transformations; underlines that 2023 offers a unique opportunity to gather momentum and undertake the urgent transformative action required to place our societies firmly on course to achieve the sdgs; warns that the consequences of inaction in this crucial year would primarily be borne by the most vulnerable people and communities;


### 3. notes that the implementation process for almost all the sdgs is lagging and that two consecutive years of regression have been recorded for many indicators9; reaffirms the importance of each sdg and highlights the key challenges that persist for sustainable development , particularly in relation to poverty (sdg1) , hunger (sdg2) , health (sdg3) , education (sdg4) , climate change (sdg 13) , oceans (sdg 14) and biodiversity (sdg 15); underlines the strategic role that sdg 10 , on reducing inequality , can play in the global implementation of the 2030 agenda; ### 3. notes that the implementation process for almost all the sdgs is lagging and that two consecutive years of regression have been recorded for many indicators9; reaffirms the importance of each sdg and highlights the key challenges that persist for sustainable development , particularly in relation to poverty (sdg 1) , hunger (sdg 2) , health (sdg 3) , education (sdg 4) , safe water and adequate sanitation for all (sdg6) , climate change (sdg 13) , oceans (sdg 14) and biodiversity (sdg 15); underlines the strategic role that sdg 10 , on reducing inequality , can play in the global implementation of the 2030 agenda;


### 5. recognises the eu’s significant role in establishing the 2030 agenda in 2015 and calls for it to take bold action and provide global leadership by setting an example in the implementation of the sdgs and redoubling its efforts ahead of the deadline; ### 5. recognises the eu’s significant role in establishing the 2030 agenda in 2015 and calls for it and its member states to take bold action and provide global leadership by setting an example in the implementation of the sdgs and redoubling its efforts ahead of the deadline;


### 6. regrets the fact that the commission has still not presented a comprehensive strategy for achieving the 2030 agenda; ### 6. recognises the potential of the european commission's comprehensive or “whole of government” approach to implementing the sdgs comprising , inter alia , the european green deal-related strategies and initiatives; regrets , however , the fact that the commission has still not presented a comprehensive strategy for achieving the 2030 agenda; stresses that the enactment of such a strategy should be preceded by a broad public participatory consultation process , including regional and local governments , all relevant civil society organizations and scientists;


### 6. regrets the fact that the commission has still not presented a comprehensive strategy for achieving the 2030 agenda; ### 6. regrets the fact that the commission has still not presented a comprehensive strategy for achieving the 2030 agenda , which should include an sdg roadmap for every commissioner’s portfolio; regrets that previous european parliament resolutions , as well as council conclusions on the sdgs , have not been yet fully implemented by the commission;


### 7. calls on the commission to continue integrating the sdgs into the european semester and to use the country-specific recommendations to systematically measure member states’ progress and set out concrete proposals for improvement; ### 7. calls on the commission to continue integrating the sdgs into the european semester and to use the country-specific recommendations to systematically measure member states’ progress and set out concrete short-term and long-term proposals for improvement; stresses that all member states should raise the level of ambition of their national responses on sdg implementation and more actively contribute to the eu action to achieve the sdgs;


### 8. stresses parliament’s important role in promoting the sdgs’ implementation through european policies and heightening the goals’ visibility in public discourse; underlines that coordination within and between the eu institutions is essential in order to ensure the eu’s leadership and increase the effectiveness of its efforts to implement the 2030 agenda; ### 8. stresses parliament’s important role in promoting the sdgs’ implementation through european policies and heightening the goals’ visibility in public discourse; underlines the importance of the european parliament using its scrutiny , legislation and budgetary powers to foster the implementation of the agenda 2030 on sustainable development in the eu and its member states , in particular by ensuring the coherence of all eu legislation with the sdgs; underlines that coordination within and between the eu institutions is essential in order to ensure the eu’s leadership as well as a multilevel governance coordination approach , capacity building and sharing of best practices , and in order to increase the effectiveness of its efforts to implement the 2030 agenda;


### 9. recalls that voluntary national reviews are the cornerstone of the follow-up and review framework for the 2030 agenda and a key accountability tool; welcomes the commission’s initiative to draft and present the first eu voluntary review report in 2023; ### 9. recalls that voluntary national reviews are the cornerstone of the follow-up and review framework for the 2030 agenda and a key accountability tool; calls on the eu to push for further standardisation of national and regional voluntary reviews , given that their content and structure differ notably from one country to another; welcomes the commission’s initiative to draft and present the first eu voluntary review report in 2023; stresses that the eu voluntary review should duly take into account the contributions provided by the civil society during the consultation process and address , among other issues , the international spillovers of eu internal policies;


### 10. reiterates the call on the commission to establish a new permanent platform for regular and structured engagement with civil society organisations in order to systematically involve them in a meaningful way in the sdg implementation process; ### 10. reiterates the call on the commission to establish a new permanent platform for regular and structured dialogue and engagement with local and regional governments , civil society organisations and scientists in order to systematically involve them in a meaningful way in the whole sdg implementation and monitoring process; recalls that ensuring diversity of expertise and interests in such platform is essential to ensure solid and functional partnerships;


### 11. underlines the importance of enhanced cooperation with partners in the global south , particularly the african union and civil society representatives , in order to implement the 2030 agenda globally; ### 11. underlines the importance of enhanced cooperation with partners in the global south , particularly the african union and civil society representatives , in order to implement the 2030 agenda globally; recalls that all impacts of european policies and expenditure affecting the sdg implementation in the global south must be properly assessed , including trough meaningful consultations with relevant stakeholders from the global south;


### 12. stresses , in this regard , that the eu and its member states must avoid negative spillover effects at the expense of the global south , which occur as a result of their past economic and technological model; advocates cooperation with global partners to turn any negative spillover effects into virtuous circles; calls for all eu policies to be subject to a mandatory sdg check to provide more insight on and address any negative effects and ensure that change in this area is measurable; ### 12. stresses , in this regard , that the eu and its member states must avoid negative spillover effects at the expense of the global south , which occur as a result of their economic and technological model; advocates cooperation with global partners to turn any negative spillover effects into virtuous circles; calls for all eu policies to be subject to a mandatory sdg check to provide more insight on and address any negative effects , including by taking mitigating action and revising legislative acts where necessary , and ensure that change in this area is measurable;


### 13. points out that , in order to assess the member states’ progress on the sdgs , the eurostat sustainable development indicators must be improved by filling the gaps for some sdgs and better measuring policies’ impact on territories and specific vulnerable groups; ### 13. points out that , in order to assess the member states’ progress on the sdgs , the eurostat sustainable development indicators must be improved by filling the gaps for some sdgs and better measuring policies’ impact on territories and specific vulnerable groups; calls on the commission to encourage member states to report on the sdg indicator 17.14.1 on policy coherence for sustainable development as part of their national reporting towards eurostat;


### 14. notes , furthermore , that important data remains unavailable on global , national and regional development policies in the global south , particularly with regard to the poorest and most marginalised people; ### 14. notes , furthermore , that important data remains unavailable on global , national and regional development policies in the global south , particularly with regard to the poorest and most marginalised people; stresses , in this regard , the importance of providing technical assistance to enhance the capacity of partner countries to collect data needed to fill in the sdg indicators , given that the reporting of the eu on the sdg impact of its projects depends on the actual data provided by partner countries;


### 15. highlights the importance of voluntary local reviews and voluntary subnational reviews as a means of further localising the sdgs and therefore advancing their implementation; ### 15. recalls that sdg implementation represents a shared responsibility , requiring action at the national , regional and local levels; highlights , in this regard , the importance of voluntary local reviews and voluntary subnational reviews as a means of further localising the sdgs and therefore advancing their implementation;


### 18. calls for the preparation of an eu financing plan for the sdgs; underlines that the 2030 agenda should guide all eu financing tools and their programming; calls on the commission to put forward a proposal for a social taxonomy to complement the green taxonomy and help implement the european green deal; ### 18. calls for the preparation of an eu financing plan for the sdgs; underlines that the 2030 agenda should guide all eu financing tools and their programming; calls on the commission to put forward a proposal for a social taxonomy to complement the green taxonomy and help implement the european green deal; underlines that the financing plan for the sdgs should address the lack of margin under heading 6 of the multiannual financial framework , which does not provide sufficient means for union’s external action to help partner countries finance their sdgs strategies;


### 19. stresses that adequate financing for the attainment of the sdgs , especially in developing countries , requires a thorough overhaul of the global financial architecture; urges the commission and the member states to step up their engagement and jointly work towards the necessary reforms of the international monetary fund , the world bank group and multilateral development banks in order to adjust these financial institutions’ visions and operating models with a focus on strengthening the fight against poverty and rising inequality and promoting a just and sustainable transition; ### 19. stresses that adequate long-term financing for the attainment of the sdgs , especially in developing countries , requires a thorough overhaul of the global financial architecture by putting in place measures for a more equitable economic and financial system , including through banking reform; urges the commission and the member states to step up their engagement and jointly work towards the necessary reforms of the international monetary fund , the world bank group and multilateral development banks in order to adjust these financial institutions’ visions and operating models with a focus on strengthening the fight against poverty and rising inequality and promoting a just and sustainable transition; points out the need to rechannel imf special drawing rights (sdrs) to developing countries and multilateral development banks (mdbs) in view of increasing sdg investment capacity without creating additional debt; underlines the need to improve the lending terms of mdbs , including lower interest rates and longer-term loans;


### 21. stresses that more than half of the world’s poorest countries face either a debt crisis or a high risk of one; welcomes the un secretary-general’s push for a global sdg stimulus package and calls for effective debt relief measures that make use of the full toolset available and include both ‘new lenders’ and private creditors; ### 21. stresses that more than half of the world’s poorest countries face either a debt crisis or a high risk of one; welcomes the un secretary-general’s push for a global sdg stimulus package and calls for effective debt relief measures that make use of the full toolset available , such as the adoption of automatic debt suspension in the event of pre-defined shocks , and include both ‘new lenders’ and private creditors; underlines the need to consider debt for sdgs swaps , which would allow many developing countries to redirect debt service payments towards sdg-related public expenditure;


### 22. recognises the importance of domestic resources being mobilised in developing countries and draws attention to the fact that this is contingent on an enabling international environment; calls on the commission and the member states to take the initiative and push for the establishment of a un intergovernmental commission for international cooperation on tax matters , in order to fight illicit financial outflows and close tax havens; ### 22. recognises the importance of domestic resources being mobilised in developing countries and draws attention to the fact that this is contingent on an enabling international environment; calls on the commission and the member states to take the initiative and push for the establishment of a un intergovernmental commission for international cooperation on tax matters , in order to fight illicit financial outflows and close tax havens; recalls that illicit financial outflows and tax havens have a severe impact on the fiscal space of developing countries and seriously undermine the rule of law and institutional resilience in these countries , which is an essential precondition to achieve sustainable development; points out that africa alone loses at least 88.6 billion dollars annually from illicit financial flows , which could bridge half of africa’s sdgs financing gap; calls on the eu , in this regard , to coherently list all the countries that qualify as tax havens in the eu listing of non-cooperative jurisdictions for tax purposes;


### 23. reiterates that the sdgs are the only globally agreed and comprehensive set of goals on the great challenges ahead and the 2030 agenda should therefore serve as a guiding light for navigating through the current uncertainties; highlights the opportunity that the sdgs provide to establish a true well-being economy centred on people and the planet and to work towards a sustainable world beyond 2030; ### 23. reiterates that the sdgs are the only globally agreed and comprehensive set of goals on the great challenges ahead for both developed and developing countries and the 2030 agenda should therefore serve as a guiding light for navigating through the current uncertainties; highlights the opportunity that the sdgs provide to establish a true well-being economy centred on people and the planet and to work towards a sustainable world beyond 2030;


### — having regard to the united nations framework convention on climate change (unfccc) , ### — having regard to the united nations framework conventions on climate change (unfccc) and on biological diversity (uncbd) ,


### b. whereas the impact of the covid-19 pandemic is not yet fully known , but has already led to a significant degree of sdg backsliding; ### b. whereas the impact of the covid-19 pandemic is not yet fully known , but has already led to a significant degree of sdg backsliding; whereas , according to the one health approach , there is evidence that human health depends on planetary health and that a healthy environment is a fundamental pillar for sustainable development;


### 12. welcomes the commission’s target of achieving a reduction of at least 10 % in the harmful use of alcohol by 2025; encourages the commission and the member states to promote actions to reduce and prevent alcohol-related harm within the framework of a revised eu alcohol strategy13 ; supports the provision of better information to consumers by improving the labelling of alcohol beverages to include prominent warning labels and introducing the mandatory indication of the list of ingredients and nutritional information; calls for the prohibition of alcohol advertising at sport events and for the prohibition of alcohol sponsorship of sport; considers it important to protect children from commercial communication on alcohol consumption , as well as product placement and sponsorship of alcohol brands , especially in the digital environment; calls for the strong monitoring of the implementation of the revised audiovisual media service directive14 ; encourages the allocation of public funds for national and european awareness campaigns; supports the planned review of eu legislation on the taxation of alcohol and on cross-border purchases of alcohol by private individuals and a review of alcohol pricing policies , including increasing taxes on alcoholic beverages; ### 12. welcomes the commission’s target of achieving a reduction of at least 10 % in the harmful use of alcohol by 2025; encourages the commission and the member states to promote actions to reduce and prevent alcohol-related harm within the framework of a revised eu alcohol strategy13; supports the provision of better information to consumers by improving the labelling of alcohol beverages to include prominent health warning labels and introducing the mandatory indication of the list of ingredients and nutritional information; calls for the prohibition of alcohol advertising at sport events and for the prohibition of alcohol sponsorship of sport; considers it important to protect children from commercial communication on alcohol consumption , as well as product placement and sponsorship of alcohol brands , especially in the digital environment; calls for the strong monitoring of the implementation of the revised audiovisual media service directive14 encourages the allocation of public funds for national and european awareness campaigns; supports the planned review of eu legislation on the taxation of alcohol and on cross-border purchases of alcohol by private individuals and a review of alcohol pricing policies , including increasing taxes on alcoholic beverages such as minimum unit pricing , and improving the harmonisation of these rules across the member states;


### 13. emphasises the role of a healthy diet in cancer prevention and that individual cancer risks can be reduced by an appropriate intake of fruits and vegetables , and therefore welcomes the upcoming revision of the ‘eu school fruit , vegetables and milk scheme’; asks the commission and the member states to help consumers to make informed , healthy and sustainable choices about food products via the adoption of harmonised , mandatory front-of-pack nutrition labelling , such as the nutri-score; welcomes the focus on healthy nutrition in the eu child guarantee15 and calls for a new eu action plan on childhood obesity; supports fiscal measures to make fresh foods (such as pulses , grains and vegetables) more affordable and accessible at national level , especially for people with low incomes; encourages member states to use pricing policies , such as value added tax differentiation , and marketing controls to influence demand for , access to and the affordability of food and drink low in saturated fats , trans-fats , salt and sugar; supports member states in restricting the advertising of ultra-processed food products and sugary and sweetened beverages , including on social media; ### 13. emphasises the role of a healthy diet in cancer prevention , in particular the mediterranean diet , and that individual cancer risks can be reduced by an appropriate intake of fruits and vegetables , and therefore welcomes the upcoming revision of the ‘eu school fruit , vegetables and milk scheme’; asks the commission and the member states to help consumers to make informed , healthy and sustainable choices about food products via the adoption of harmonised , mandatory front-of-pack nutrition labelling , such as the nutri-score; welcomes the focus on healthy nutrition in the eu child guarantee15 and calls for a new eu action plan on childhood obesity; supports fiscal measures to make fresh foods (such as pulses , grains and vegetables) more affordable and accessible at national level , especially for people with low incomes; takes the view that access to higher-quality food products is facilitated by short marketing channels , which should provide real support for small and medium-sized agricultural producers , who follow more sustainable practices , ensuring fair prices for production , a stable and decent income for farmers and food sovereignty for every state; encourages member states to use pricing policies , such as value added tax differentiation , and marketing controls to influence demand for , access to and the affordability of food and drink low in saturated fats , trans-fats , salt and sugar; supports member states in restricting the advertising of ultra-processed food products and sugary and sweetened beverages , including on social media;


### 13. emphasises the role of a healthy diet in cancer prevention and that individual cancer risks can be reduced by an appropriate intake of fruits and vegetables , and therefore welcomes the upcoming revision of the ‘eu school fruit , vegetables and milk scheme’; asks the commission and the member states to help consumers to make informed , healthy and sustainable choices about food products via the adoption of harmonised , mandatory front-of-pack nutrition labelling , such as the nutri-score; welcomes the focus on healthy nutrition in the eu child guarantee15 and calls for a new eu action plan on childhood obesity; supports fiscal measures to make fresh foods (such as pulses , grains and vegetables) more affordable and accessible at national level , especially for people with low incomes; encourages member states to use pricing policies , such as value added tax differentiation , and marketing controls to influence demand for , access to and the affordability of food and drink low in saturated fats , trans-fats , salt and sugar; supports member states in restricting the advertising of ultra-processed food products and sugary and sweetened beverages , including on social media; ### 13. emphasises the role of a healthy diet in cancer prevention and that individual cancer risks can be reduced by an appropriate intake of fruits and vegetables , and therefore welcomes the upcoming revision of the ‘eu school fruit , vegetables and milk scheme’; asks the commission and the member states to help consumers to make informed , healthy and sustainable choices about food products via the adoption of eu-wide harmonised , mandatory front-of-pack nutrition labelling that is interpretative and uniform , such as the nutri-score , that rules out exemptions to specific products including regionally produced products; welcomes the focus on healthy nutrition in the eu child guarantee15 and calls for a new eu action plan on childhood obesity; supports fiscal measures to make fresh foods (such as pulses , grains and vegetables) more affordable and accessible at national level , especially for people with low incomes; encourages member states to use pricing policies , such as value added tax differentiation , and marketing controls to influence demand for , access to and the affordability of food and drink low in saturated fats , transfats , salt and sugar; supports member states in restricting the advertising of ultra-processed food products and sugary and sweetened beverages , including on social media; calls on the commission to enforce new measures to stimulate food product reformulation , notably for products and drinks high in fat , salt and sugar (hfss) and for foods for infants and young children;


### 18. sees the european green deal as a contributing factor in cancer prevention in europe , via the reduction of air , food , water and soil pollution and of chemical exposure; calls for an evaluation of the impact of policies on cancer incidence to be integrated into the farm to fork strategy and the chemical , zero pollution and non-toxic environment strategies; welcomes the upcoming revision of the eu’s air quality standards to align them with who guidelines; calls on the commission to ensure that the common agricultural policy reduces the intake of pesticide residues; encourages the use and development of medicines that are safer for the environment; ### 18. sees the european green deal as a critical advancement as well as a contributing factor in advancing cancer prevention in europe , via the reduction of air , food , water and soil pollution and of chemical exposure , including chemical-pharmaceutical residues and residues of chemical products used in agriculture; calls for an evaluation of the impact of policies on cancer incidence to be integrated into the farm to fork strategy and the chemical , zero pollution and non-toxic environment strategies; welcomes the upcoming revision of the eu’s air quality standards to align them with who guidelines; calls on the commission to ensure that the common agricultural policy reduces the usage of , and exposure to , the intake of pesticide residues; encourages the use and development of medicines that are safer for the environment;


### 18. sees the european green deal as a contributing factor in cancer prevention in europe , via the reduction of air , food , water and soil pollution and of chemical exposure; calls for an evaluation of the impact of policies on cancer incidence to be integrated into the farm to fork strategy and the chemical , zero pollution and non-toxic environment strategies; welcomes the upcoming revision of the eu’s air quality standards to align them with who guidelines; calls on the commission to ensure that the common agricultural policy reduces the intake of pesticide residues; encourages the use and development of medicines that are safer for the environment; ### 18. sees the european green deal as a contributing factor in cancer prevention in europe , via the reduction of air , food , water and soil pollution and of chemical exposure; calls on the commission to encourage and support initiatives to prevent the importing of items containing carcinogenic chemicals; calls , furthermore , for eu measures to strengthen food monitoring for chemicals , including pesticides; calls for an evaluation of the impact of policies on cancer incidence to be integrated into the farm to fork strategy and the chemical , zero pollution and non-toxic environment strategies; welcomes the upcoming revision of the eu’s air quality standards to align them with who guidelines; calls on the commission to ensure that the common agricultural policy reduces the intake of pesticide residues; encourages the use and development of medicines that are safer for the environment;


### 19. looks forward to the implementation of the revised drinking water directive19 and the implementation and enforcement of the water framework directive20 , which will reduce the concentrations in surface and ground waters of certain pollutants that could contribute to cancer incidence; ### 19. looks forward to the implementation of the revised drinking water directive19 and the implementation and enforcement of the water framework directive20 , which will reduce the concentrations in surface and ground waters of certain pollutants that could contribute to cancer incidence; takes the view that the right to water is a universal right and that if everyone is to be guaranteed that right and able to access water that is high quality , water (and sanitation) services must remain public;


### 21. considers that the next review of the european code against cancer (ecac) will have to take into account the latest knowledge on environmental carcinogens; calls for the regulation on food contact materials22 to be reviewed in order to reduce exposure to carcinogens and endocrine disruptors; ### 21. considers that the next review of the european code against cancer (ecac) will have to take into account the latest knowledge on environmental carcinogens; calls for the regulation on food contact materials22 to be reviewed in order to reduce exposure to carcinogens and endocrine disruptors; the next review of ecac should be coordinated by the international agency for research on cancer and it should support a systematic evaluation of the code , including greater clarity as to how the ambition to achieve 80 % awareness of the ecac’s messages will be measured;


### 22. recalls that exposure at work is responsible for at least 120 000 deaths from cancer each year in the eu; looks forward to the forthcoming new eu strategic framework on health and safety at work for the 2021-2027 period , the regular update of directive 2004/37/ec of 29 april 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work23 , and the addition of further binding occupational exposure limits within that directive; welcomes the commission’s commitment to presenting a legislative proposal to further reduce workers’ exposure to asbestos in 2022; asks member states to facilitate recognition of and compensation for proven work-related cancers; stresses the need to ensure the best possible general and individual protection measures for healthcare workers handling anti-cancer drugs; ### 22. recalls that exposure at work is responsible for at least 120 000 deaths from cancer each year in the eu and that 8% of all cancer cases are work-related , making up 12% of cancer cases among men and 7% of cancer cases among women; looks forward to the forthcoming new eu strategic framework on health and safety at work for the 2021-2027 period , the regular update of directive 2004/37/ec of 29 april 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work23 , and the addition of further binding occupational exposure limits within that directive; stresses that 50 priority carcinogens have been identified and that workers are widely exposed to them in europe , but that binding occupational exposure limit values exist to date for only 27 of them; calls for the scope of the carcinogens and mutagens directive (directive 2004/37/ec - cmd) to be extended to include substances toxic to reproduction and dangerous medicines and for a new coherent , transparent and risk-based system for setting exposure limits to be established; welcomes the commission’s commitment to presenting a legislative proposal to further reduce workers’ exposure to asbestos in 2022; asks member states to facilitate recognition of and compensation for proven work-related cancers; stresses the need to ensure the best possible general and individual protection measures for healthcare workers handling anti-cancer drugs;


### 22. recalls that exposure at work is responsible for at least 120 000 deaths from cancer each year in the eu; looks forward to the forthcoming new eu strategic framework on health and safety at work for the 2021-2027 period , the regular update of directive 2004/37/ec of 29 april 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work23 , and the addition of further binding occupational exposure limits within that directive; welcomes the commission’s commitment to presenting a legislative proposal to further reduce workers’ exposure to asbestos in 2022; asks member states to facilitate recognition of and compensation for proven work-related cancers; stresses the need to ensure the best possible general and individual protection measures for healthcare workers handling anti-cancer drugs; ### 22. recalls that exposure at work is responsible for at least 120 000 deaths from cancer each year in the eu; looks forward to the forthcoming new eu strategic framework on health and safety at work for the 2021-2027 period and the close and regular involvement of stakeholders in this , the regular update of directive 2004/37/ec of 29 april 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work , and the addition of further binding occupational exposure limits within that directive , including exposure to hazardous drugs (e.g. for healthcare professionals) and to uv radiation (e.g. for outdoor workers); welcomes the commission’s commitment to presenting a legislative proposal to further reduce workers’ exposure to asbestos in 2022; asks member states to facilitate recognition of and compensation for proven work-related cancers; stresses the need to ensure the best possible general and individual protection measures for healthcare workers handling anti-cancer drugs;


### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated with uterine , cervical and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states to ensure the elimination of all hpv-related cancers; considers it important to draw up further recommendations to better implement these programmes; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination; supports further research into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy; ### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated to almost 5% of all cancers in women and men worldwide , including cervical , anal , penile , vaginal , vulval and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states to ensure the elimination of all hpv-related cancers; insists that the eu goal for hpv vaccination for girls and boys be understood as 90% in both cases; considers it important to draw up further recommendations to better implement these programmes; urges that progress towards the goals of europe's beating cancer plan on hpv vaccination be reported within the cancer inequalities registry; recommends that the successful and applauded covid-19 vaccine tracker developed by the european centre for disease control and prevention be replicated for hpv vaccination; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination; supports further research into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy; utilising eu4health and other eu funding streams for this purpose , including for support to awareness-raising efforts with citizens , education providers and healthcare professional as well as for support to behavioural research under the horizon europe programme; ensuring strengthened application of the eu's code of practice on disinformation particularly with regard to vaccine misinformation;


### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated with uterine , cervical and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states to ensure the elimination of all hpv-related cancers; considers it important to draw up further recommendations to better implement these programmes; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination; supports further research into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy; ### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated with uterine , cervical , vaginal , vulvar , penile , anal and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states to ensure the elimination of all hpv-related cancers; subject to localized context-specific evaluations; calls for improving the uptake of hpv vaccination in line with the who global strategy on the elimination of cervical cancer encompassing vaccination but also screening , access to treatment , and rehabilitation; considers it important to draw up further recommendations to better implement these programmes; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination , encourages the regular monitoring of current hpv and hepatitis b vaccination at european level; supports further research into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy;


### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated with uterine , cervical and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states to ensure the elimination of all hpv-related cancers; considers it important to draw up further recommendations to better implement these programmes; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination; supports further research into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy; ### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated with uterine , cervical and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states , subject to localized context-specific evaluations , to ensure the elimination of all hpv-related cancers; calls for improving the uptake of hpv vaccination in line with the who global strategy on the elimination of cervical cancer encompassing prevention , educational programs , vaccination as well as screening , access to treatment and rehabilitation; considers it important to draw up further recommendations to better implement these programmes; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination; supports further research into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy;


### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated with uterine , cervical and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states to ensure the elimination of all hpv-related cancers; considers it important to draw up further recommendations to better implement these programmes; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination; supports further research into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy; ### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated with uterine , cervical and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states to ensure the elimination of all hpv-related cancers; considers it important to draw up further recommendations to better implement these programmes; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination; supports further research , anticipatory as well as responsive , into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy;


### 25. points out that genetic predisposition to cancer linked to mutations of specific genes has been demonstrated; highlights that methods to detect these mutations are available , especially for breast and colorectal cancers , and may help to prevent or detect early-stage cancer; recommends investments in infrastructures and skills in genetic sequencing platforms and the training of specialised genetic counsellors; ### 25. points out that genetic predisposition to cancer linked to mutations of specific genes has been demonstrated; highlights that methods to detect these mutations are available , especially for breast and colorectal cancers , and may help to prevent or detect early-stage cancer; recommends investments in infrastructures and skills in genetic sequencing platforms and the training of specialised genetic counsellors; urges to raise awareness about citizens' access to such services across europe via exercises such as the cancer inequalities registry;


### 27. encourages the commission and the member states to promote health literacy as regards cancer risks and determinants , to develop educational tools for prevention and to support the creation of e-learning platforms and applications; considers cancer prevention to be a first step towards a european public health education policy; ### 27. encourages the commission and the member states to promote health literacy as regards cancer risks and determinants , to develop educational tools for prevention and to support the creation of e-learning platforms and applications; considers cancer prevention to be a first step towards a european public health education policy and highlights that particular attention should be paid to disadvantaged , vulnerable , socially excluded , and marginalized people; calls for the use of all available prevention tools including alternative reduced risk tools , alcohol-prevention strategies , and nutritional campaigns;


### 28. calls for the creation of a virtual european cancer institute , which would be in charge of establishing a european roadmap to devise and coordinate large-scale prevention campaigns and effective communication campaigns on health promotion in educational programmes (harmless behaviours , healthy nutrition , physical activity etc.) with a special focus on young people and disadvantaged groups; ### 28. calls for the creation of a virtual european cancer institute , which would be in charge of establishing a european roadmap to devise and coordinate large-scale prevention campaigns and effective communication campaigns on health promotion in educational programmes (harmless behaviours , healthy nutrition , physical activity , as well as integrative medicine interventions aimed at health restoration , etc.) with a special focus on young people and disadvantaged groups;


### 29. underlines that tobacco and alcohol consumption , poor nutrition , a high body mass index and a sedentary lifestyle are risk factors common to other chronic diseases; believes , therefore , that cancer prevention has to be implemented in the context of an integrated chronic disease prevention programme , in close cooperation with the steering group on health promotion , disease prevention and management of non-communicable diseases; ### 29. underlines that tobacco , harmful alcohol consumption , poor nutrition , a high body mass index and a sedentary lifestyle are risk factors common to other chronic diseases; believes , therefore , that cancer prevention has to be implemented in the context of an integrated chronic disease prevention programme , in close cooperation with the steering group on health promotion , disease prevention and management of non-communicable diseases;


### 31. deplores the frequent delays to cancer diagnosis related to a lack of information or adherence to cancer screening and detection processes; recognises the need to pay particular attention to the continuity of screening programmes and early detection in the context of a health crisis (such as the covid-19 crisis); ### 31. deplores the frequent delays to cancer diagnosis related to a lack of information or adherence to cancer screening and detection processes; recognises the need to pay particular attention to the continuity of screening programmes and early detection in the context of a health crisis (such as the covid-19 crisis); considers that stepping up public health services (including financial aspects , infrastructure and aspects involving health professionals) is key to increasing and speeding up cancer prevention , screening and diagnosis;


### 32. notes that , for instance , only 18 member states reported that they had national or regional population-based screening programmes in place; regrets the inequalities between member states in access to breast cancer screening , which differs at least tenfold across the eu according to eurostat; ### 32. notes that , for instance , only 18 member states being reported to have national or regional population-based screening programmes for breast , cervical and colorectal cancers in the most recent report by iarc on progress towards achieving the 2003 council recommendations on screening; regrets the inequalities between member states in access to screening , which , in the case of breast cancer as an example , differs at least tenfold across the eu according to eurostat; points out that the 'health at a glance: europe 2018' publication noted a similar difference in coverage of target population ranges between member states of 25% to 80% for cervical cancer screening;


### 33. invites member states to work together to reduce inequalities in cancer screening and early diagnosis services , especially in cross-border regions; ### 33. invites member states to work together to reduce inequalities in cancer screening and early diagnosis services , especially in cross-border regions , including by sharing best practices in a more coordinated way , such as through a european platform for national screening agencies;


### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025; ### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025; calls for the inclusion of lung cancer screening of the high-risk population in the upcoming cancer screening scheme according to the latest scientific evidence; and calls for the establishment of a permanent platform to enable the networking of cancer screening programme coordinators , facilitate the training and capacity-building for improving quality in screening programmes , act as central hub for projects and initiatives on cancer supported by the eu , and maintain in the long term the network of data providers to the implementation report by the iarc on cancer screening in the european union;


### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025; ### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025 and calls for the establishment of a permanent platform to enable the networking of cancer screening programme coordinators , facilitate the training and capacity-building for improving quality in screening programmes , act as central hub for projects and initiatives on cancer screening supported by the eu , and maintain in the long term the network of data providers to the implementation report by the iarc on cancer screening in the european union;


### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025; ### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025; urges the commission to take measures for monitoring and regular reporting via the cancer inequalities registry towards the achievement of this goal;


### 35. encourages member states to promote cancer screening for breast , cervical and colorectal cancers as part of organised population-based national and regional programmes , including in the remote and outermost regions , and provide adequate resources; recommends that member states roll out programmes for early clinical detection of oral and skin cancers; ### 35. encourages member states to promote cancer screening for breast , cervical and colorectal cancers as part of organised population-based national and regional programmes , including in the remote and outermost regions , and provide adequate resources; encourages the commission and the member states to promote targeted screening for high-risk groups such as hereditary breast cancer , based on the available evidence; recommends that member states roll out programmes for early clinical detection of oral and skin cancers;


### 35. encourages member states to promote cancer screening for breast , cervical and colorectal cancers as part of organised population-based national and regional programmes , including in the remote and outermost regions , and provide adequate resources; recommends that member states roll out programmes for early clinical detection of oral and skin cancers; ### 35. encourages member states to promote cancer screening for breast , cervical and colorectal cancers as part of organised population-based national and regional programmes , including in the remote and outermost regions , and provide adequate resources; recommends that member states introduce research programs , investigate quality assured public health programmes for early clinical detection of oral and skin cancers and implement evidence-based treatment guidelines;


### 36. calls for the full implementation by member states of the european guidelines for quality assurance in cancer screening for breast , cervical and colorectal cancers and early detection services , to minimise the delay to diagnosis for such cancers; recommends that inequalities within member states regarding screening be addressed , possibly by making the criteria for cancer screening , as well as the legal frameworks , governance and quality assurance structures , more stringent; ### 36. calls on the european commission and member states for the full implementation of the european guidelines for quality assurance in cancer screening for breast , cervical , and colorectal cancers; early detection services to minimise the delay to diagnosis for such cancers; recommends that inequalities within member states regarding screening be addressed , possibly by making the criteria for cancer screening , as well as the legal frameworks , governance and quality assurance structures , more stringent; recommends the inclusion of as many as possible different medical professions in the screening process , including dental professionals;


### 38. welcomes the upcoming update of the 2003 council recommendation on breast , cervical and colorectal cancer screening24 to take into account new screening tests and the most recent data on the best screening protocols (magnetic resonance imaging , hpv testing); emphasises that those programmes should be regularly evaluated by the competent national authorities; calls for research efforts to be fostered in order to assess , in close cooperation with the iarc and the who , the possible inclusion of new science-based cancer screening programmes (including lung , prostate , stomach and ovarian cancers) in the recommendation; ### 38. welcomes the upcoming update of the 2003 council recommendation on breast , cervical and colorectal cancer screening24 to take into account new screening tests and the most recent data on the best screening protocols (magnetic resonance imaging , hpv testing); emphasises that those programmes should be regularly evaluated by the competent national authorities; calls to recognise the extensive body of evidence that proves the positive effect of targeted lung cancer screening; encourages the council to include lung and prostate cancer screening in the update of the council recommendations in 2022; calls the council to mandate the commission to develop eu guidelines;


### 38. welcomes the upcoming update of the 2003 council recommendation on breast , cervical and colorectal cancer screening24 to take into account new screening tests and the most recent data on the best screening protocols (magnetic resonance imaging , hpv testing); emphasises that those programmes should be regularly evaluated by the competent national authorities; calls for research efforts to be fostered in order to assess , in close cooperation with the iarc and the who , the possible inclusion of new science-based cancer screening programmes (including lung , prostate , stomach and ovarian cancers) in the recommendation; ### 38. welcomes the upcoming update of the 2003 council recommendation on breast , cervical and colorectal cancer screening24 to take into account new screening tests and the most recent data on the best screening protocols (magnetic resonance imaging , hpv testing); calls for lung cancer screening guidelines in line with the most recent scientific evidence; emphasises that those programmes should be regularly evaluated by the competent national authorities; calls for research efforts to be fostered in order to assess , in close cooperation with the iarc and the who , the possible inclusion of new science-based cancer screening programmes (including lung , prostate , stomach and ovarian cancers) in the recommendation;


### 38. welcomes the upcoming update of the 2003 council recommendation on breast , cervical and colorectal cancer screening24 to take into account new screening tests and the most recent data on the best screening protocols (magnetic resonance imaging , hpv testing); emphasises that those programmes should be regularly evaluated by the competent national authorities; calls for research efforts to be fostered in order to assess , in close cooperation with the iarc and the who , the possible inclusion of new science-based cancer screening programmes (including lung , prostate , stomach and ovarian cancers) in the recommendation; ### 38. welcomes the upcoming update of the 2003 council recommendation on breast , cervical and colorectal cancer screening24 to take into account new screening tests and the most recent data on the best screening protocols (magnetic resonance imaging , hpv testing); emphasises that those programmes should be regularly evaluated by the competent national authorities; calls for anticipatory and responsive research efforts to be fostered in order to assess , in close cooperation with the iarc and the who , the possible inclusion of new science-based cancer screening programmes (including lung , prostate , stomach and ovarian cancers) in the recommendation;


### 39. advocates the launch of a platform for national screening centres to share expertise and implement best practices , discuss common challenges and encourage collaboration , based on the model of the european network for health technology assessment (eunethta); ### 39. advocates the launch of a platform for national screening centres to share expertise and implement best practices , discuss common challenges and encourage collaboration , drawing on the experience of similar platforms for exchange and cooperation such as the european network for health technology assessment (eunethta) and the heads of medicines agencies (hma);


### 40. stresses the importance of increasing the uptake of cancer screening and early detection among eu citizens through european awareness days , motivation surveys and better implementation of existing communication campaigns; ### 40. stresses the importance of increasing awareness about , and the uptake of , cancer screening and early detection among eu citizens via union-wide awareness campaigns , european awareness days , motivation surveys and better implementation of existing communication campaigns; encourages research into behavioural adherence factors to boost participation in screening programmes , supported by european funding such as the horizon europe research programme;


### 40. stresses the importance of increasing the uptake of cancer screening and early detection among eu citizens through european awareness days , motivation surveys and better implementation of existing communication campaigns; ### 40. stresses the importance of increasing the uptake of cancer screening and early detection among eu citizens through european awareness days , motivation surveys and better implementation of existing communication campaigns with special attention to balanced information on advantages and disadvantages;


### 41. calls for reinforced cooperation with third countries to encourage the organisation of screening campaigns , in particular for women’s cancers and notably in low- and middle-income countries; ### 41. calls for reinforced cooperation with third countries to encourage the organisation of screening campaigns , in particular for women’s cancers and notably in low- and middle-income countries; this can mark an important contribution by the eu towards the achievement of international goals in cancer , such as the who goal for the elimination of cervical cancer as a public health problem;


### 41. calls for reinforced cooperation with third countries to encourage the organisation of screening campaigns , in particular for women’s cancers and notably in low- and middle-income countries; ### 41. calls for reinforced cooperation with third countries to encourage the organisation of screening campaigns , in particular for women’s cancers and notably in low- and middle-income countries and with minority communities.


### 42. deplores the fact that eu patients still face challenges in accessing healthcare services in other member states and that only a minority of patients are aware of their right to seek cross-border healthcare; emphasises the need for better implementation of , and an improved financial model for , the cross-border healthcare directive25 to allow for mobility and access to highly specialised equipment and care through the reinforcement of the national contact points (ncps) by providing them with more budgetary resources , and calls for an increase in the number of information campaigns on patients’ rights to cross-border healthcare; emphasises the need to facilitate the process , through the revision of the cross-border healthcare directive , for patients who travel abroad for clinical trials and face issues such as a lack of clarity on follow-up protocols after their return home and on coverage of costs related to their clinical trial participation by national insurance agencies; calls on the commission and the member states to work together to conduct regular evaluations of the commission’s ehealth strategy from 2018 to ensure interconnected electronic health records for cancer patients at regional , national and european level; ### 42. deplores the fact that eu patients still face challenges in accessing healthcare services in other member states and that only a minority of patients are aware of their right to seek cross-border healthcare; emphasises the need for better implementation of , and an improved financial model for , the cross-border healthcare directive25 to allow for mobility and access to highly specialised equipment and care through the reinforcement of the national contact points (ncps) by providing them with more budgetary resources , and calls for an increase in the number of information campaigns on patients’ rights to cross-border healthcare; emphasises the need to facilitate the process , through the revision of the cross-border healthcare directive , for patients who travel abroad for clinical trials and face issues such as a lack of clarity on follow-up protocols after their return home and on coverage of costs related to their clinical trial participation by national insurance agencies; calls on the commission and the member states to work together to conduct regular evaluations of the commission’s ehealth strategy from 2018 to ensure interconnected electronic health records for cancer patients at regional , national and european level; notes the potential of the cancer inequalities registry as a means of reporting and measuring improvement on these concerns;


### 43. calls for consideration of mutual recognition of medical qualifications in cancer care across the eu; ### 43. calls for consideration of mutual recognition of medical qualifications in cancer care across the eu , while ensuring that it is facilitative and not obstructive to the mutual recognition of qualifications for oncology related specialties;


### 44. calls for full recognition of medical oncology as a specialist discipline , the establishment of pan-european quality standards for administering and supervising medical treatments for cancer , and the facilitation of patients’ access to cancer specialists so that they may benefit from innovations and access to early clinical trials on new promising drugs; ### 44. calls for full recognition of medical oncology as a specialist discipline , the establishment of pan-european quality standards for administering and supervising medical treatments for cancer , and the facilitation of patients’ access to cancer specialists so that they may benefit from innovations and access to early clinical trials on new promising health technologies;


### 46. supports the improvement of high-quality radiation therapy in the eu through the recognition of medical physics and radiation therapy as dedicated disciplines , the promotion of common education and training standards , and the greater investment of eu and national research and innovation funds in radiation therapy research; ### 46. supports the improvement of , and an increased access to , high-quality radiation therapy in the eu through the recognition of medical physics and radiation therapy as dedicated disciplines , the promotion of common education and training standards , increased funding for member states to expand their radiation therapy infrastructure , and the greater investment of eu and national research and innovation funds in radiation therapy research;


### 48. calls on the commission to promote , and on member states to strengthen , the role of general practitioners , paediatricians and primary care professionals , given their importance in patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary decision-making in the framework of dedicated concertation meetings bringing together various cancer specialists; ### 48. calls on the commission to promote , and on member states to strengthen , the role of general practitioners , paediatricians and primary care professionals , given their importance in patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary care teams (mdt) to manage cancer patients throughout their treatment journey; stresses that mdts should include a specialised oncology nutritionist or dietician , given the high prevalence and impact of nutritional issues from diagnosis through to end-of-life;


### 48. calls on the commission to promote , and on member states to strengthen , the role of general practitioners , paediatricians and primary care professionals , given their importance in patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary decision-making in the framework of dedicated concertation meetings bringing together various cancer specialists; ### 48. calls on the commission to promote , and on member states to strengthen , the role of general practitioners , paediatricians and primary care professionals , including oral health professionals , given their importance in cancer prevention , early detection , patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary decision-making in the framework of dedicated concertation meetings bringing together various cancer specialists;


### 48. calls on the commission to promote , and on member states to strengthen , the role of general practitioners , paediatricians and primary care professionals , given their importance in patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary decision-making in the framework of dedicated concertation meetings bringing together various cancer specialists; ### 48. calls on the commission to promote , and on member states to strengthen , the role of family doctors , general practitioners , paediatricians and primary care professionals , given their importance in patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary decision-making in the framework of dedicated concertation meetings bringing together various cancer specialists;


### 48. calls on the commission to promote , and on member states to strengthen , the role of general practitioners , paediatricians and primary care professionals , given their importance in patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary decision-making in the framework of dedicated concertation meetings bringing together various cancer specialists; ### 48. calls on the commission to promote , and on member states to strengthen , the role of general practitioners , paediatricians and primary care professionals , given their importance in patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary decision-making in the framework of dedicated cross-discipline conferences and concertation meetings bringing together various cancer specialists;


### 50. calls on the member states to take preventive measures against the risk of burnout among cancer care professionals; ### 50. calls on the member states to take preventive measures against the risk of burnout among cancer care professionals; urges that dg empl and eu-osha provide attention to this concern , and be considered important implementation partners of europe’s beating cancer plan in this respect;


### 50. calls on the member states to take preventive measures against the risk of burnout among cancer care professionals; ### 50. calls on the member states to develop , within their national cancer control plans , strategies that encompass and implement preventive measures against the risk of burnout among cancer care professionals;


### 51. encourages , where possible and safe , the use of ambulatory cancer treatments in order to preserve the quality of life of patients; calls on member states to implement or improve e-health technologies and telemedicine services to ensure the continuity of cancer care; ### 51. encourages , where possible and safe , the use of ambulatory cancer treatments in order to preserve the quality of life of patients; calls on member states to implement or improve e-health technologies and telemedicine services to ensure the continuity of cancer care; urges the deployment of horizon europe research funding to support the use of telemedicine , and to assist the establishment of evidence-based guidelines; calls for actions to ensure equal access to telemedicine services across the member states and foreu4health and digital europe funding support to increase digital literacy for patients and healthcare professionals;


### 51. encourages , where possible and safe , the use of ambulatory cancer treatments in order to preserve the quality of life of patients; calls on member states to implement or improve e-health technologies and telemedicine services to ensure the continuity of cancer care; ### 51. encourages , where possible and safe , the use of ambulatory cancer treatments in order to preserve the quality of life of patients; calls on member states to implement or improve e-health technologies and telemedicine services to ensure the continuity of cancer care outside hospital;


### 51. encourages , where possible and safe , the use of ambulatory cancer treatments in order to preserve the quality of life of patients; calls on member states to implement or improve e-health technologies and telemedicine services to ensure the continuity of cancer care; ### 51. encourages , where feasible and safe , the use of ambulatory cancer treatments in order to preserve the quality of life of patients; calls on member states to implement or improve e-health technologies and telemedicine services to ensure the continuity of cancer care outside hospital and in the community;


### 52. calls on the member states to provide optimal relief for advanced-stage cancer patients at the end of their lives in order to ease their pain and discomfort while preserving their dignity; supports more intensive exchanges and the implementation of best practices on hospice and palliative care at eu level; encourages member states to assess the number of palliative units in each region and to ensure sustainable funding and sufficient and well-trained human resources; ### 52. calls on the member states to provide , within their national cancer control plans , optimal relief for advanced-stage cancer patients in order to ease their pain and discomfort at the end of their lives- while preserving their dignity and taking into account the autonomy of the patient and his or hers needs; calls on the commission to support and coordinate regular exchange of information and the implementation of best practices on hospice and palliative care at eu level; encourages member states to assess the number of palliative units in each region and to ensure sustainable funding and sufficient and well-trained human resources;


### 52. calls on the member states to provide optimal relief for advanced-stage cancer patients at the end of their lives in order to ease their pain and discomfort while preserving their dignity; supports more intensive exchanges and the implementation of best practices on hospice and palliative care at eu level; encourages member states to assess the number of palliative units in each region and to ensure sustainable funding and sufficient and well-trained human resources; ### 52. calls on the member states to provide optimal relief for advanced-stage cancer patients at the end of their lives in order to ease their pain and discomfort while preserving their dignity; supports more intensive exchanges and the implementation of best practices on hospice and palliative care at eu level; encourages member states to assess the number of palliative units in each region and to ensure sustainable funding and sufficient and well-trained human resources; urges that patients' access to pain management , supportive and palliative care (including psycho-oncology services) across europe be measured and reported via the cancer inequalities registry;


### 52. calls on the member states to provide optimal relief for advanced-stage cancer patients at the end of their lives in order to ease their pain and discomfort while preserving their dignity; supports more intensive exchanges and the implementation of best practices on hospice and palliative care at eu level; encourages member states to assess the number of palliative units in each region and to ensure sustainable funding and sufficient and well-trained human resources; ### 52. calls on the member states to provide optimal relief for advanced-stage cancer patients at the end of their lives in order to ease their pain and discomfort while preserving their dignity; supports more intensive exchanges and the implementation of best practices on hospice and palliative care at eu level; encourages member states to assess the number of palliative units in each region and to ensure sustainable funding and sufficient and well-trained human resources , and to create a network of public facilities that provides this response;


### 53. encourages the commission and the member states to adopt specific quality assurance criteria (including adequate organisations , infrastructures and competences , multidisciplinary practice , continuing education for professionals , patient education and participation in clinical research) for accreditation standards to be applied to public and private hospitals treating cancer patients , in order to ensure the efficient , safe and equal management of cancers all over the eu; ### 53. encourages the commission and the member states to adopt within the national comprehensive cancer centers , national cancer strategies and policies specific quality assurance criteria (including adequate organisations , infrastructures and competences , multidisciplinary practice , continuing education for professionals , patient education and participation in clinical research) for accreditation standards to be applied to public and private hospitals treating cancer patients , in order to ensure the efficient , safe and equal management of cancers all over the eu;


### 54. welcomes the planned establishment , as announced in europe’s beating cancer plan , of an eu network linking recognised national comprehensive cancer centres (reference centres) in every member state to facilitate the uptake of quality-assured diagnosis and treatments , including training , research and promotion of clinical trials across the eu; calls on the commission to identify such existing centres within the eu , to promote the establishment of at least one comprehensive cancer centre in each member state and to support the coordination of the network of these centres via a european cancer institute; ### 54. welcomes the planned establishment , as announced in europe’s beating cancer plan , of an eu network linking recognised national comprehensive cancer centres (reference centres) in every member state to facilitate the uptake of quality-assured diagnosis and treatments , including training , research and promotion of clinical trials across the eu; calls on the commission to identify such existing centres within the eu , to promote the establishment of at least one comprehensive cancer centre in each member state and to support the coordination of the network of these centres via a european cancer institute; recommends the establishment of core objectives for the new network of centres as an early task; stresses that these objectives should include the reduction of inequalities , strengthening of translational , clinical and outcomes research , and integration of clinical care and research;